human albumin csl behring 200 g/l inf. sol. i.v. vial
csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin
water for injection csl behring parent. solv. parent. vial
csl behring gmbh - water for injection 2 ml - solvent for parenteral use - solvents and diluting agents, incl. irrigating solutions
water for injection csl behring parent. solv. parent. vial
csl behring gmbh - water for injection 2 ml - solvent for parenteral use - solvents and diluting agents, incl. irrigating solutions
beriate 500 powder and solvent for solution for injection/ infusion
csl behring gmbh - human blood coagulation factor viii - powder and solvent for solution for injection/ infusion - 500iu
beriate 1000 powder and solvent for solution for injection/ infusion
csl behring gmbh - human blood coagulation factor viii - powder and solvent for solution for injection/ infusion - 1000iu
berinert iv human c1 esterase inhibitor 1500 iu powder for injection vial with diluent vial
csl behring australia pty ltd - water for injections, quantity: 3 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).
berinert iv human c1 esterase inhibitor 500 iu powder for injection vial with diluent vial
csl behring australia pty ltd - water for injections, quantity: 10 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).
berinert sc human c1 esterase inhibitor 3000 iu powder for injection glass vial with diluent vial
csl behring australia pty ltd - c1 esterase inhibitor, quantity: 3000 iu - injection, diluent for - excipient ingredients: - berinert? sc for subcutaneous injection is indicated for prevention of recurrent hereditary angioedema (hae) attacks in patients aged 8 years and older with c1 esterase inhibitor deficiency.
berinert sc human c1 esterase inhibitor 2000 iu powder for injection glass vial with diluent vial
csl behring australia pty ltd - c1 esterase inhibitor, quantity: 2000 iu - injection, diluent for - excipient ingredients: - berinert? sc for subcutaneous injection is indicated for prevention of recurrent hereditary angioedema (hae) attacks in patients aged 8 years and older with c1 esterase inhibitor deficiency.
medicine administration kit, percutaneous, medicated, single-use
csl behring australia pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - the procedure pack consists of: mix2vial, venipuncture set, disposable 10ml syringe, alcohol swabs and plaster/adhesive bandage. the mix2vial is used to transfer the diluent from the diluent vial to the medicine vial. the reconstituted medicine is drawn through the mix2vial into the syringe. the syringe containing the medicine is then connected to the venipuncture set to facilitate intravenous injection of the medicine. alcohol swabs are provided to wipe the rubber stopper of each vial before the mix2vial is applied. the plaster/adhesive bandage is provided to cover the injection site after administration of medicine.